Titolo:  Pathophysiological roles for purines: adenosine, caffeine and urate
Autori: 
Data di pubblicazione:  2010
Rivista: 
PROGRESS IN BRAIN RESEARCH  
Abstract:  The motor symptoms of Parkinson's disease (PD) are primarily due to the degeneration of the dopaminergic neurons in the nigrostriatal pathway. However, several other brain areas and neurotransmitters other than dopamine such as noradrenaline, 5-hydroxytryptamine and acetylcholine are affected in the disease. Moreover, adenosine because of the extensive interaction of its receptors with the dopaminergic system has been implicated in the pathophysiology of the disease. Based on the involvement of these non-dopaminergic neurotransmitters in PD and the sometimes severe adverse effects that limit the mainstay use of dopamine-based anti-parkinsonian treatments, recent assessments have called for a broadening of therapeutic options beyond the traditional dopaminergic drug arsenal. In this review we describe the interactions between dopamine and adenosine receptors that underpin the pre-clinical and clinical rationale for pursuing adenosine A(2A) receptor antagonists as symptomatic and potentially neuroprotective treatment of PD. The review will pay particular attention to recent results regarding specific A(2A) receptor-receptor interactions and recent findings identifying urate, the end product of purine metabolism, as a novel prognostic biomarker and candidate neuroprotectant in PD.
Handle:  http://hdl.handle.net/11584/100799
ISBN:  978-0-444-53750-8
Tipologia: 2.1 Contributo in volume (Capitolo o Saggio)

File in questo prodotto:
Non ci sono file associati a questo prodotto.

Questionario e social

Condividi su: